Cargando...

Non-factor replacement therapy for haemophilia: a current update

One of the most challenging issues facing us in the treatment of haemophilia is the development of alloantibodies against infused factor VIII (FVIII) or factor IX (FIX). Inhibitors render factor replacement therapy ineffective, exposing patients to an unacceptably high risk of morbidity and mortalit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood Transfus
Autores principales: Franchini, Massimo, Mannucci, Pier Mannuccio
Formato: Artigo
Lenguaje:Inglês
Publicado: Edizioni SIMTI - SIMTI Servizi Srl 2018
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6125230/
https://ncbi.nlm.nih.gov/pubmed/29517971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2018.0272-17
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!